Archives
-
WIP1 Limits Renal Pyroptosis via p38 MAPK in Septic AKI
2026-08-03
This study uncovers a protective role for WIP1 phosphatase in suppressing p38 MAPK-driven pyroptosis during sepsis-associated acute kidney injury. By clarifying the molecular link between WIP1 and inflammatory cell death in renal tissue, the research provides a mechanistic basis for targeting WIP1 in future interventions against septic AKI.
-
lncRNA FAISL Blocks Calpain-2 Cleavage of FAK in TNBC Progre
2026-08-03
The reference study identifies lncRNA FAISL as a stabilizer of FAK protein in triple negative breast cancer (TNBC) by inhibiting calpain-2-mediated proteolysis. This mechanistic insight clarifies a novel regulatory axis in TNBC progression and highlights new avenues for targeted intervention.
-
MLKL Polymerization Drives Lysosomal Disruption in Necroptos
2026-08-02
This study reveals that MLKL polymerization induces lysosomal membrane permeabilization (LMP), leading to cathepsin B–dependent cell death during necroptosis. The findings clarify a crucial mechanistic link between MLKL amyloid-like assemblies and regulated necrotic cell death, with implications for targeting lysosomal proteases in disease contexts.
-
Super-Enhancer–FOXA1–SLC7A11 Axis Drives Disulfidptosis in P
2026-08-01
This study by Kang et al. uncovers how a super-enhancer upstream of SLC7A11, via FOXA1, governs a newly recognized cell death pathway—disulfidptosis—in prostate cancer. The findings highlight a mechanistically distinct vulnerability that could inform targeted strategies, especially in metabolically stressed tumor contexts.
-
Dimetridazole-Cefotaxime Synergy Against MDR E. coli: Mechan
2026-07-31
Wei et al. provide rigorous evidence that dimetridazole, a 1,2-dimethyl-5-nitroimidazole, restores cefotaxime efficacy against multidrug-resistant E. coli by disrupting membrane integrity and altering fatty acid composition. This work illuminates new avenues for membrane-targeted antibiotic combinations in resistance research.
-
Mechanisms of Tiamulin Interaction and Resistance in Bacteri
2026-07-31
This article reviews a structural and biochemical investigation into how Tiamulin, a pleuromutilin antibiotic, binds the bacterial ribosome and how mutations confer resistance. The findings clarify drug–ribosome interactions and highlight strategies for optimizing pleuromutilin derivatives to combat emerging resistance in veterinary pathogens.
-
ACE2 Activation via Diminazene Aceturate Protects Against Se
2026-07-30
This study demonstrates that pharmacological activation of ACE2 using Diminazene Aceturate mitigates sepsis-induced cardiomyopathy in mice by enhancing MasR-Sirt1-mediated mitochondrial biogenesis. The findings clarify mechanistic pathways underlying cardiac protection in sepsis, informing new research strategies for targeting mitochondrial dysfunction in infection-driven cardiac injury.
-
CSRP2 Regulates PRC1-Mediated PDGFRA/PI3K/AKT Signaling in G
2026-07-30
This study uncovers a novel regulatory axis in glioblastoma, showing that CSRP2 modulates the PDGFRA/PI3K/AKT pathway via PRC1 complex components. The findings clarify epigenetic mechanisms in mesenchymal gliomas and identify CSRP2 as a potential biomarker, with implications for future targeted therapies.
-
RBMS1 Loss Sensitizes TNBC to PD-L1 Blockade via Glycosylati
2026-07-29
The reference study uncovers RBMS1 as a crucial post-transcriptional regulator of PD-L1 stability in triple-negative breast cancer (TNBC), revealing that RBMS1 loss destabilizes B4GALT1 mRNA and reduces PD-L1 glycosylation. This mechanism enhances anti-tumor T cell responses and potentiates immune checkpoint therapy, informing new combinatorial immunotherapy strategies.
-
Prestained Protein Marker (Triple color, EDTA free, 10-250 k
2026-07-29
The Prestained Protein Marker (Triple color, EDTA free, 10-250 kDa) provides visible, multi-color molecular weight standards for SDS-PAGE and Western blot workflows, enabling real-time protein separation monitoring and transfer verification without EDTA interference. It should be used where precise band tracking, phosphoprotein compatibility, and fluorescent membrane imaging are required, but is not suitable when unstained markers or non-overlapping molecular weight ranges are essential.
-
TBK1 Inhibition Alleviates Painful Diabetic Neuropathy via M
2026-07-28
Liao et al. (2024) demonstrate that targeting TANK-binding kinase 1 (TBK1) reduces painful diabetic neuropathy (PDN) by suppressing microglia-mediated pyroptosis. This mechanistic insight identifies TBK1 inhibition as a promising strategy for addressing neuroinflammatory complications in diabetes models.
-
Structural Insights into Tiamulin-Ribosome Interaction and R
2026-07-28
This article analyzes the 2006 study that elucidates how tiamulin and other pleuromutilin antibiotics bind the ribosomal peptidyl transferase center, uncovering structural bases for both drug action and resistance. These findings directly inform rational design of improved veterinary antibiotics and help guide laboratory applications in research and clinical contexts.
-
I-BET151 (GSK1210151A): Technical Guidance for BET Inhibitio
2026-07-27
I-BET151 (GSK1210151A) is designed for researchers investigating BET protein function, transcriptional regulation, and oncogenic pathways—especially in cancer biology and apoptosis studies. It is not suited for diagnostic or therapeutic applications, and strict adherence to storage and handling protocols is required to ensure data reproducibility.
-
Bile Acid Retention Impairs Antigen Presentation in MASH-HCC
2026-07-27
This study reveals that bile acid retention within tumor cells suppresses NLRC5-mediated MHC-I antigen presentation, enabling immune evasion in metabolic dysfunction-associated steatohepatitis-related hepatocellular carcinoma (MASH-HCC). By elucidating the GPR120–bile acid–NLRC5 axis, the work identifies novel targets for restoring tumor immunogenicity and improving immunotherapy outcomes.
-
Viral Degradation of RIPK3 Modulates Necroptosis and Inflamm
2026-07-26
This study uncovers a class of orthopoxvirus proteins (vIRD) that target the necroptosis adaptor RIPK3 for ubiquitin-mediated degradation, suppressing necroptosis and reshaping the host inflammatory response. These findings reveal a mechanistic link between viral immune evasion and the SCF ubiquitin ligase complex, offering new insights into host-pathogen interactions.